This third joint event between Bristol and Cardiff, and involving researchers from NHS Trusts and the University of Bath, focussed on three areas: DNA Repair, metastasis, and stem cells. Over 60 people registered for the event.
The programme included 10-minute talks by:
- Dr Anna Chambers (CRUK Career Development Fellow, School of Biochemistry, Bristol): The HELLS chromatin remodelling protein contributes to maintenance of genome stability
- Prof Simon Reed (School of Medicine, Cardiff): INDUCE-seq: detecting breaks in the thread of life
- Prof Anne Ridley (Head of School of Cellular and Molecular Medicine, Bristol): Role of cancer cell: endothelial cell interactions in metastasis
- Dr Florian Siebzehnrubl (Research Fellow, European Cancer Stem Cell Research Institute, Cardiff): The role of EMT transcription factors in non-epithelial cancers
- Dr Allison Blair (Principal Clinical Scientist, School of Cellular and Molecular Medicine, Bristol): New targets for ALL therapy
- Dr Fernando dos Anjos-Afonso (Research Fellow, European Cancer Stem Cell Research Institute, Cardiff): A newly defined human blood stem cell population: impact on the origin and evolution of human myeloid leukaemias
The presentations were followed by round-table discussions in break-out rooms.
Participants are eligible to apply for a £5,000 seed fund which is supported by the University Cancer Research Fund at Bristol and Cardiff's Development and Alumni Relations Department thanks to generous donations from graduates and members of the public. Applications must have at least one co-investigator from each institution and priority will be given to submissions from early career researchers.
The next joint cancer event will be hosted by Cardiff.